Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes from the CATIE-AD Effectiveness Trial

OBJECTIVE: To measure the effects of atypical antipsychotic medication on psychiatric and behavioral symptoms in patients with Alzheimer’s disease (AD) and psychosis or agitated behavior. METHOD: The CATIE-AD effectiveness study included 421 outpatients with AD and psychosis or agitated/aggressive b...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sultzer, David L., Davis, Sonia M., Tariot, Pierre N., Dagerman, Karen S., Lebowitz, Barry D., Lyketsos, Constantine G., Rosenheck, Robert A., Hsiao, John K., Lieberman, Jeffrey A., Schneider, Lon S.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2714365/
https://ncbi.nlm.nih.gov/pubmed/18519523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ajp.2008.07111779
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires